ClinicalTrials.Veeva

Menu

Relation of Circulating Endothelium-derived Microparticle to Carotid Atherosclerosis

K

Kurume University

Status

Completed

Conditions

Atherosclerosis

Study type

Observational

Funder types

Other

Identifiers

NCT00795067
KurumeU-08060

Details and patient eligibility

About

The investigators hypothesized that circulating endothelium-derived microparticle (EMP) may be a useful surrogate marker of atherosclerosis and future episode of cerebrovascular events. Peripheral blood is drawn at the time of carotid ultrasound examination. Circulating EMPs are counted using flow-cytometry. The correlation among circulating EMP, ultrasound findings, and atherosclerotic risk factors are determined by multiple stepwise regression analysis. The prevalence of cerebrovascular events is also determined during 3-year follow-up period.

Enrollment

154 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients who undergo carotid ultrasound examination for screening of atherosclerosis

Exclusion criteria

  • Cerebrovascular events within the last 12 months
  • Acute coronary syndrome, coronary and peripheral intervention within the last 6 months
  • Uncontrolled heart failure
  • Other severe systemic diseases

Trial design

154 participants in 1 patient group

Carotid atherosclerosis group
Description:
Patients who undergo carotid ultrasound examination for carotid atherosclerosis screening

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems